Shares of Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) traded up 5.5% during trading on Thursday. The company traded as high as $3.86 and last traded at $3.9250. Approximately 6,260 shares changed hands during trading, a decline of 92% from the average session volume of 78,430 shares. The stock had previously closed at $3.72.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, October 8th. One analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, the company has an average rating of “Hold”.
Read Our Latest Report on NNNN
Anbio Biotechnology Stock Down 0.3%
The firm has a 50 day moving average price of $6.10 and a 200 day moving average price of $15.11.
About Anbio Biotechnology
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Further Reading
- Five stocks we like better than Anbio Biotechnology
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
